Anchiano Therapeutics is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer.
View Top Employees from Anchiano TherapeuticsWebsite | https://www.anchiano.com |
Ticker | ANCN |
Revenue | $2 million |
Employees | 15 (2 on RocketReach) |
Founded | 2004 |
Address | One Kendall Square BLDG 1400E, STE 14-105, Cambridge, Massachusetts 02139, US |
Phone | +972 2-548-6555 |
Technologies |
JavaScript,
HTML,
PHP
+24 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Oncology, Business Services, Science and Engineering, Gene Therapy, Health Care, NMIBC, Medical Device, Bladder Cancer, Cancer, Target Therapy, Immunotherapy |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Anchiano Therapeutics employee's phone or email?
The Anchiano Therapeutics annual revenue was $2 million in 2024.
2 people are employed at Anchiano Therapeutics.
Anchiano Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Anchiano Therapeutics are [32, 3254, 32541, 325].
The SIC codes for Anchiano Therapeutics are [283, 28].